Nomenclature
CAS number: 63612-50-0
5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione; 1-(3′-trifluoromethyl-4′-nitrophenyl)-4,4-dimethylimidazoline-2,5-dione; RU-23908; Anandron (Cassenne); Nilandron (Aventis).
C
12H
10F
3N
3O
4; mol wt 317.22.
C 45.43%, H 3.18%, F 17.97%, N 13.25%, O 20.17%.
Description and references
Nonsteroidal antiandrogen. Prepn: J. Perronnet et al., DE 2649925; eidem, US 4097578 (1977, 1978 both to Roussel-UCLAF). Pharmacology: J.-P. Raynaud et al., J. Steroid Biochem. 11, 93 (1979).
Review of kinetics, metabolism and clinical studies: idem et al., Prog. Clin. Biol. Res. 185A, 99-120 (1985); of therapeutic efficacy in prostate
cancer: M. G. Harris et al., Drugs
Aging 3, 9-25 (1993).
Properties
Crystals from ethanol, mp 149°. Freely sol in ethyl acetate, acetone,
chloroform, ethanol, dichloromethane, methanol. Soly in water at
25°: < 0.1%.Therapeutic Category
Antineoplastic (hormonal).
Keywords
Antiandrogen; Antineoplastic (Hormonal); Antiandrogens